Repligen
RGENRepligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symb …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Repligen
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 11/21/2024 | Sell | Hunt, Anthony | Director | $139.7 | $3,386,439 |
| 9/10/2024 | Sell | Hunt, Anthony | Director | $145.3 | $3,225,928 |
| 8/2/2024 | Sell | Kuriyel, Ralf | Senior VP, R&D | $159.1 | $1,139,016 |
| 8/1/2024 | Sell | Kuriyel, Ralf | Senior VP, R&D | $165.7 | $739,717 |
| 6/14/2024 | Buy | Hunt, Anthony | Chief Executive Officer | $124.1 | $248,160 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)